HighTower Advisors’s Usana Health Sciences USNA Stock Holding History
Bought
Maintained
Sold
Other funds holding USNA
HighTower Advisors's USNA Position: Q3 2023 in Review
HighTower Advisors sold out of Usana Health Sciences (USNA) in Q3 2023, closing a stake of 3,324 shares — an estimated $224K sold.
HighTower Advisors first reported a position in USNA in Q1 2014 and held it in 17 quarters. The position peaked at $1.91M in Q1 2021. 160 funds tracked by Wall St. Rank hold USNA as of Q3 2023.
- HighTower Advisors reported no remaining Usana Health Sciences position as of Q3 2023 after selling out during the quarter.
- HighTower Advisors sold 3,324 Usana Health Sciences shares in Q3 2023, an estimated $224K.
- HighTower Advisors first reported a position in Usana Health Sciences in Q1 2014 and held it in 17 quarters.
- HighTower Advisors's Usana Health Sciences position peaked at $1.91M in Q1 2021.
- 160 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2023.
Based on HighTower Advisors's 13F filing for Q3 2023, filed 8 Nov 2023.